Limited coverage criteria – mometasone

Last updated on March 19, 2025

 

Return to Special Authority drug list

Generic name

mometasone nasal spray

Strength & form

 

Special Authority criteria

Approval period

For patients between ages 3 to 11 years with a diagnosis of allergic rhinitis

Until the patient's 12th birthday

Practitioner exemptions

  • None

Special Authority request form(s)